Skip to main content

CollPlant Biotechnologies Ltd

CLGN
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001631487

No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding CollPlant Biotechnologies Ltd changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of CLGN: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders2116−5
Shares1.80M1.72M−83.3K (−4.6%)
Value$29.5M$19.5M−$10.0M (−34.1%)

New holders (2)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to CLGN in Q1 2022
InstitutionSharesValue% of portfolio
Geneos Wealth Management Inc.750$8.00K0.00%
Wells Fargo & Company100$1.00K0.00%

Sold out (7)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of CLGN in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Zurcher Kantonalbank (Zurich Cantonalbank)24,623$403.0K
Weil Company, Inc.21,210$347.0K
Kingsview Wealth Management, LLC18,415$301.0K
LPL Financial LLC14,770$242.0K
HRT Financial LP13,531$221.0K
Sigma Planning Corp13,070$214.0K
Susquehanna International Group, LLP10,578$173.0K